Teva Pharmaceutical plans to cut 5,000 employees as part of global restructuring plan

Teva Pharmaceuticals says it will cut 5,000 employees by the end of next year as part of a restructuring designed to slim the drugmaker’s business and make it more efficient.

The Israeli company says the cuts amount to a 10 per cent global workforce reduction. The drugmaker plans to trim oversized parts of its business while growing its generic and core research and development programs.

Teva says the moves are part of a global restructuring it announced in 2012. It now expects to save about $2 billion annually by the end of 2017, largely due to a reduction in the company’s cost of goods.

Teva Pharmaceutical Industries Ltd. is one of the world’s largest generic drugmakers. It has struggled in recent quarters with declining sales for both generic and brand-name drugs.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.